CEACAM19 Antibodies

Santa Cruz Biotechnology delivers a wide array of CEACAM19 monoclonal antibodies for research focused on understanding this important protein. CEACAM19 monoclonal antibodies are suitable for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). CEACAM19, a member of the carcinoembryonic antigen (CEA) family, plays a significant role in cell adhesion and signaling processes. Its expression is particularly relevant in certain cancers, making CEACAM19 an essential target for cancer research and diagnostics. Understanding CEACAM19 function can provide insights into tumor progression and potential therapeutic strategies. Researchers can utilize CEACAM19 monoclonal antibodies to explore cellular mechanisms and pathways involved in cancer development. Advanced detection methods, including horseradish peroxidase (HRP), phycoerythrin (PE), and fluorescein isothiocyanate (FITC) conjugates, enable precise visualization and quantification of CEACAM19 expression patterns. CEACAM19 research continues to reveal new aspects of cancer biology and potential treatment approaches. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing scientific understanding of CEACAM19 and its role in cancer development.